Coenzymes & Antioxidants
Cyanocobalamin
Also known as Vitamin B12
Last reviewed: 2026-11-19
Evidence status & limitations
Specific approved medicines address vitamin B12 deficiency; evidence in deficiency is not evidence of extra benefit in people with normal B12 status.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Nascobal · Vitamin B12 Deficiency
Specified adult B12-deficiency treatment or prevention and maintenance of pernicious-anemia remission without nervous-system involvement, under the product’s labeled conditions.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Allergic reactions are possible; neurological symptoms need evaluation rather than assumed vitamin deficiency.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Glutathione
Same scientific class · A 3-amino-acid chain. · Early human trials
- Nicotinamide adenine dinucleotide
Same scientific class · A small chemical molecule, not a peptide. · Early human trials